Limited stability of Hepatitis B virus RNA in plasma and serum
- PMID: 39511219
- PMCID: PMC11543676
- DOI: 10.1038/s41598-024-77329-2
Limited stability of Hepatitis B virus RNA in plasma and serum
Abstract
Pregenomic hepatitis B virus RNA (HBV pgRNA) is a potential biomarker in the management of HBV infected patients. However, prior to the use in routine clinical practice potential confounders of test results need to be identified. This study investigates the stability of HBV pgRNA under various storage conditions. HBV-RNA level of 26 HBV patients were determined using the Roche cobas® 6800/8800 investigational HBV-RNA assay. Plasma and serum were stored for 6,48,169 h at 4,25 and 42 °C, respectively. Additionally, 10 serum and plasma samples underwent 4 or 11 cycles of freezing (-80 °C) and thawing (25 °C). A significant decline in mean pgRNA concentration compared to baseline was observed after storage for 48 h at 25 °C as well as after 6 h of storage at 42 °C. Accordingly, sub-analyses of predefined pgRNA baseline concentrations (≤ 10 cp/mL, > 10-100 cp/ml, > 100 cp/mL) revealed significant changes in pgRNA level after storage at 25 and 42 °C. No effect of freezing and thawing on pgRNA level was observed. A qualitative detection of HBV pgRNA is feasible in samples with > 100 cp/mL up to 48 h under storage temperatures of 4-42 °C. For most stable quantitative HBV pgRNA values storage at 4 °C should be preferred.
Keywords: Hepatitis B virus; Pregenomic HBV RNA; Relapse; Stability; Treatment cessation.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- World Health Organization. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017 Licence: CC BY-NC-SA 3.0 IGO. 10.1149/2.030203jes (2017).
-
- Chan, S. L., Wong, V. W. S., Qin, S. & Chan, H. L. Y. Infection and cancer: The case of hepatitis B. J. Clin. Oncol.34(1), 83–90. 10.1200/JCO.2015.61.5724 (2016). - PubMed
-
- Marcellin, P. et al. Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection. Liver Int.39(10), 1868–1875. 10.1111/liv.14155 (2019). - PubMed
-
- Lampertico, P. et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J. Hepatol.67(2), 370–398. 10.1016/j.jhep.2017.03.021 (2017). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
